These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15327439)

  • 1. Prevention of acute renal failure with N-acetylcysteine--enough is enough?
    Koller H; Rosenkranz AR
    Kidney Int; 2004 Sep; 66(3):1292-3; author reply 1292-3. PubMed ID: 15327439
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-Induced Acute Kidney Injury: Comparison of Preventative Therapies.
    Honicker T; Holt K
    Nephrol Nurs J; 2016; 43(2):109-16; quiz 117. PubMed ID: 27254966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery.
    Sisillo E; Marenzi G
    J Clin Pharmacol; 2011 Nov; 51(11):1603-10. PubMed ID: 21233303
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal protection by N-acetylcysteine.
    Shehabi Y
    Br J Anaesth; 2007 Feb; 98(2):270; author reply 270-1. PubMed ID: 17251216
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure.
    Morgan PG; Georghiou M; Flynn F; Jaggar S
    Br J Anaesth; 2007 Jul; 99(1):143; author reply 143-4. PubMed ID: 17573400
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury.
    Kizilgun M; Poyrazoglu Y; Oztas Y; Yaman H; Cakir E; Cayci T; Akgul OE; Kurt YG; Yaren H; Kunak ZI; Macit E; Ozkan E; Taslipinar MY; Turker T; Ozcan A
    Ren Fail; 2011; 33(5):512-7. PubMed ID: 21545313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "N-acetylcysteine (NAC) protects against acute kidney injury following prolonged pneumoperitoneum".
    Shebrain S
    J Surg Res; 2011 Dec; 171(2):e179-80. PubMed ID: 22001183
    [No Abstract]   [Full Text] [Related]  

  • 8. A drug to prevent renal failure?
    Kellum JA
    Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT Investigators
    Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carfilzomib-related acute kidney injury may be prevented by N-acetyl-L-cysteine.
    Wanchoo R; Khan S; Kolitz JE; Jhaveri KD
    J Oncol Pharm Pract; 2015 Aug; 21(4):313-6. PubMed ID: 24748581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Q: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury?
    Sivalingam SK; Hariharan MV; Braden GL; Freda BJ
    Cleve Clin J Med; 2012 Nov; 79(11):746-9. PubMed ID: 23125323
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Ataei S; Hadjibabaie M; Moslehi A; Taghizadeh-Ghehi M; Ashouri A; Amini E; Gholami K; Hayatshahi A; Vaezi M; Ghavamzadeh A
    Hematol Oncol; 2015 Jun; 33(2):67-74. PubMed ID: 24711000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexpanthenol and N-acetylcysteine pretreatment in rats before renal ischemia/reperfusion injury.
    Sen H; Deniz S; Yedekci AE; Inangil G; Muftuoglu T; Haholu A; Ozkan S
    Ren Fail; 2014 Nov; 36(10):1570-4. PubMed ID: 25156619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of hypes and hopes: N-acetylcysteine and cystatin C.
    Schultz MJ; Royakkers AA; Bouman CS
    AJR Am J Roentgenol; 2008 Mar; 190(3):W224; author reply W225. PubMed ID: 18287418
    [No Abstract]   [Full Text] [Related]  

  • 15. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to the treatment of acute renal failure.
    Venkataraman R; Kellum JA
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2579-92. PubMed ID: 11060821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of acute kidney injury.
    Brincat S; Hilton R
    Br J Hosp Med (Lond); 2008 Aug; 69(8):450-4. PubMed ID: 18783092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
    Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
    J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine (NAC) protects against acute kidney injury (AKI) following prolonged pneumoperitoneum in the rat.
    Seguro AC; Poli de Figueiredo LF; Shimizu MH
    J Surg Res; 2012 Jun; 175(2):312-5. PubMed ID: 21764077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of acute renal failure.
    Venkataraman R; Kellum JA
    Chest; 2007 Jan; 131(1):300-8. PubMed ID: 17218591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.